In discriminating AFP-negative HCC from benign liver diseases and liver metastasis (HL, LC and MT), a similar AUC (0.845, 95% CI 0.793–0.898, sensitivity: 76.3%, specificity: 82.2%, Fig 5C) was found. This evidence concerns the gene AFP and hepatocellular carcinoma.